AIDS
Conditions
Interventions
Group 1:Yiaikang capsule
Group 2:placebo
Sponsors
The First Affiliated Hospital of Henan University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed as HIV/AIDS (according to standard WS293-2008); 2. Being accepted highly active anti-retroviral therapy; 3. CD4+T cell count is less than 250 /ul; 4. Participant aged 18 to 65 years oldmales or females; 5. Attend the study signed the informed consent voluntarily, and complete the visitation.
Exclusion criteria
Exclusion criteria: 1. Severe heart, liver and kidney diseases, gastrointestinal bleeding, mental disordersneurological diseases and coagulation disorders; 2. Combined with pulmonary infection and / or multiple opportunistic infections; 3. Pregnant or breastfeeding women, and refuse to use regular birth control method during the study; 4. Received other investigational drugs within 3 months; 5. Allergic or or intolerant to the trial drug; 6. Alcoholism ,alcohol abstinence less than 6 months; 7. Patients that are inappropriate base on investigators opinion( those are in poor health or cant follow the visit).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of pulmonary infectious diseases; | — |
Secondary
| Measure | Time frame |
|---|---|
| CD4T cell counts;Symptoms and signs of traditional Chinese Medicine; | — |
Countries
China
Contacts
Public ContactLIU Zhibin
The First Affiliated Hospital of Henan University of Chinese Medicine
Outcome results
None listed